000 | 01994 a2200589 4500 | ||
---|---|---|---|
005 | 20250516130612.0 | ||
264 | 0 | _c20130730 | |
008 | 201307s 0 0 eng d | ||
022 | _a1098-6596 | ||
024 | 7 |
_a10.1128/AAC.01821-12 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVinot, C | |
245 | 0 | 0 |
_aPlacental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cMar 2013 |
||
300 |
_a1415-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xgenetics |
650 | 0 | 4 | _aChromatography, Liquid |
650 | 0 | 4 |
_aCyclohexanes _xmetabolism |
650 | 0 | 4 | _aDiffusion Chambers, Culture |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFetus |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aHIV Fusion Inhibitors _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMaraviroc |
650 | 0 | 4 | _aMaternal-Fetal Exchange |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xgenetics |
650 | 0 | 4 | _aOrgan Culture Techniques |
650 | 0 | 4 | _aPerfusion |
650 | 0 | 4 |
_aPlacenta _xdrug effects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aTandem Mass Spectrometry |
650 | 0 | 4 |
_aTriazoles _xmetabolism |
700 | 1 | _aGavard, L | |
700 | 1 | _aTréluyer, J M | |
700 | 1 | _aManceau, S | |
700 | 1 | _aCourbon, E | |
700 | 1 | _aScherrmann, J M | |
700 | 1 | _aDeclèves, X | |
700 | 1 | _aDuro, D | |
700 | 1 | _aPeytavin, G | |
700 | 1 | _aMandelbrot, L | |
700 | 1 | _aGiraud, C | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 57 _gno. 3 _gp. 1415-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01821-12 _zAvailable from publisher's website |
999 |
_c22399295 _d22399295 |